Aehr Test Systems heads into its July 8 earnings print with short sellers actively covering, the stock staging a volatile weekly reversal, and borrow conditions that have loosened dramatically from earlier in the year.
The most striking shift in positioning this week is the rapid short cover. Short interest has fallen 8.4% over the past week to 13.1% of the free float — roughly 3.94 million shares — and is down 15.6% from a month ago. That sustained covering trend through May and into June tells a clear story: shorts that built positions aggressively earlier in the year are now pulling back ahead of the July print. With a days-to-cover reading of 1.77, there is still a meaningful short base, but the direction of travel is firmly lower. On the borrow side, cost-to-borrow is running at 0.51% — up 32% on the week, which sounds dramatic but remains very cheap in absolute terms. More telling is the availability picture: with an availability reading above 1,000%, the lending pool is essentially wide open. That is a complete reversal from May, when availability had tightened to the 220–340% range and borrow conditions were genuinely firmer. The loosening of the lending market over the past three weeks mirrors the covering trend and confirms that short-side pressure is easing, not building. Options positioning has also turned more constructive. The put/call ratio has dropped to 0.92 — below its 20-day average of 0.94 and well below the 1.07 peak hit in early June — suggesting options traders have rotated away from the defensive hedging posture that dominated the first days of the month.
The Street picture is harder to read cleanly, because all recent analyst coverage is stale by at least two months, and the mean price target of roughly $64 sits well below the current price of $104.83 — a gap significant enough that those targets should not be taken as current views. What can be said is that the last directional move from a named firm was William Blair's upgrade to Outperform in early March, and the stock has run dramatically since. Valuation multiples have become extreme as the price has moved: the P/E sits at 479x and EV/EBITDA at 234x, both of which have expanded sharply over the past 30 days. The ORTEX short score has eased to 49.5 from 51.7 a week ago, drifting toward neutral from a mildly bearish read. Factor scores reflect the tension: momentum and growth-forward signals are decent, but quality ranks low, and EPS momentum over both the 30- and 90-day windows is in the bottom couple of percentiles — pointing to rapid near-term estimate cuts even as longer-dated growth forecasts remain elevated.
The ownership register adds one layer worth flagging. T. Rowe Price added 1.31 million shares as of the March quarter-end, making it one of the larger new institutional positions in recent months. Goldman Sachs added over 1 million shares in the same period. BlackRock's most recent filing (May 31) shows a further 159,000-share addition. The clustering of institutional buying from multiple large shops in Q1 and into Q2 suggests the stock has attracted genuine fundamental interest — not just short-covering mechanics. Insider activity, by contrast, has been one-way selling. The CFO sold shares in both May and early June. A director sold nearly $714,000 worth in mid-May. Every disclosed insider trade over the past 90 days is a sale, with net proceeds totalling around $19.5 million. That is a pattern worth noting alongside the institutional buying: institutions accumulating, insiders distributing.
The price action this week captures the underlying tension sharply. AEHR closed at $104.83 on Tuesday, down 9.5% on the day after an 11.2% gain on the week — a 20-point intraday swing that reflects how lightly held positions can be at these levels. Closest peers moved in a tighter range: TER gained 10.9% on the week while AMKR surged 22%, suggesting broader semiconductor equipment names also caught a bid, but MPWR fell 2.2% and NVTS slipped 3.3%, so the sector was far from uniform. The most recent earnings history is relevant here: the April 7 print triggered a 21% next-day gain and a 42.6% five-day rally. The prior print produced a 31.7% jump and a 73.9% five-day move. Those are large-magnitude reactions in both directions of the prior two events landing positive — a stock where the options market's current near-neutral PCR may be underpricing event risk.
With the next earnings date set for July 8, the coming three weeks will be shaped by whether the covering trend in short interest continues or pauses, and whether the wide gap between the current price and stale analyst targets attracts fresh price-target upgrades that could anchor a new range.
See the live data behind this article on ORTEX.
Open AEHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
